Stocks and Finance

Amgen

Amgen 5/23/2012

16:43 : New CEO takes the helm at biotech giant Amgen - WESTLAKE VILLAGE, Calif. (AP) -- Biotech drugmaker Amgen Inc. has introduced new CEO Bob Bradway to shareholders at the company's annual meeting, with retiring CEO Kevin Sharer stepping down after a decade....
Source : usnews-com

Amgen 4/28/2012

04:17 : DBJ Weekend Tech Watch: Yahoo, Facebook, Apple, Google, Amgen and more - Welcome to the Denver Business Journal's Weekend Tech Watch, our roundup of top tech news from around the nation, featuring reports on Yahoo, Facebook, Apple, Google, Amgen, Clearwire, ...
Source : bizjournals-com

Amgen 4/25/2012

00:21 : Amgen 1Q profit up 5 pct, beats Wall Street views - TRENTON, N.J. (AP) -- Biotech giant Amgen Inc. said Tuesday that its first-quarter profit rose 5 percent on higher sales of its top two drugs and two new ones, and it easily beat Wall Street forecasts....
Source : usnews-com

Amgen 4/24/2012

15:37 : Amgen first-quarter profit rises 5.2% - SAN FRANCISCO (MarketWatch) -- Amgen Inc. said late Tuesday that its first-quarter profit rose to $1.18 billion, or $1.48 a share, from $1.13 billion, or $1.20 a share, in the year-ago period. Excluding one-time items, the biotech firm would ...
Source : marketwatch-com
07:59 : Bayer To Develop Cancer Treatment With Amgen - German chemical and pharmaceutical company Bayer AG (BAYN.XE) said Tuesday it has agreed with Amgen Inc. (AMGN) to develop and commercialize a new antibody for treating cancer.
Source : foxbusiness-com

Amgen 4/11/2012

12:12 : Amgen To Buy Kai Pharmaceuticals For $315M - Global biopharmaceutical firm Amgen, Inc. (NASDAQ: AMGN) has agreed to buy KAI Pharmaceuticals, a privately held company based in San Francisco, for $315 million in cash.
Source : ibtimes-com

Amgen 4/10/2012

08:16 : Amgen to buy KAI Pharma - BOSTON (MarketWatch) -- Amgen Inc. said early Tuesday that it plans to buy privately-held KAI Pharmaceuticals for $315 million in cash. KAI's lead product candidate, KAI-4169, is in mid-stage development for the treatment of hyperparathyroidism ...
Source : marketwatch-com
07:59 : Amgen (AMGN) acquires privately-held KAI Pharmaceuticals for $315M in ... - Amgen (AMGN) acquires privately-held KAI Pharmaceuticals for $315M in a deal that will give it widespread rights for kidney disease treatment KAI-4169. As part of the agreement between the firms, Amgen has provided a loan to enable ...
Source : seekingalpha-com

Amgen 4/3/2012

03:47 : AstraZeneca Partners with Amgen to Develop Inflammation Portfolio - AstraZeneca, an Anglo-Swedish biopharmaceutical company has entered into an agreement with Amgen, US biotechnology company to develop and commercialise five monoclonal antibodies from Amgen's clinical inflammation portfolio.
Source : ibtimes-com

Amgen 4/2/2012

21:11 : MedImmune central to AstraZeneca-Amgen antibody deal - Pharmaceutical giants AstraZeneca PLC and Amgen Inc. just announced a deal to co-develop and co-commercialize five product candidates, all monoclonal antibodies. No surprise here: MedImmune LLC – AZ’s Gaithersburg-based biologics arm that ...
Source : bizjournals-com
16:04 : Amgen, AstraZeneca team on 5 experimental drugs - SAN FRANCISCO (MarketWatch) -- Amgen Inc. and AstraZeneca PLC said late Monday they were partnering to further develop and try to bring to market five biotech drugs candidates from Amgen's collection. Under the agreement, AstraZeneca will ...
Source : marketwatch-com
15:54 : Amgen, Astra to collaborate on several drugs - (Reuters) - Amgen Inc and British drugmaker AstraZeneca Plc announced on Monday a major collaboration deal to jointly develop and sell five biotech drugs currently in Amgen's developmental pipeline.
Source : reuters-com
15:50 : Amgen (AMGN) and AstraZeneca (AZN) have agreed to collaborate on the devel - Amgen (AMGN) and AstraZeneca (AZN) have agreed to collaborate on the development and commercialization of 5 drugs in Amgen's clinical inflammation porfolio. AstraZeneca will lead the way in developing 3 of the 5 drugs. AstraZeneca will make ...
Source : seekingalpha-com

Amgen 3/1/2012

17:04 : Judge refuses to halt Amgen-Micromet deal - DOVER, Del. (AP) -- A Delaware judge has refused to delay the acquisition of Micromet Inc. by Amgen Inc., the world's largest biotech company. The judge ruled that Micromet shareholders have not shown ...
Source : usnews-com

Amgen 2/20/2012

10:13 : Dako Enters into an Additional Collaboration with Amgen on Developing ... - GLOSTRUP, DENMARK--(Marketwire - Feb 20, 2012) - Dako, a world leading independent cancer diagnostic supplier with 45 years of experience in pathology, announced today that it has entered into a new collaboration agreement with Amgen Inc. ...
Source : marketwire-com

Amgen 2/6/2012

12:18 : FDA questions Amgen drug for prostate cancer - (02-06) 08:11 PST WASHINGTON, CA (AP) -- Scientists for the Food and Drug Administration say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not...
Source : sfgate-com

Amgen 1/26/2012

17:09 : Amgen 4Q profit down 9 pct., but sales up 3 pct. - THOUSAND OAKS, Calif. (AP) -- Amgen Inc. said Thursday that its fourth-quarter profit fell 8.5 percent as its expenses for taxes and producing and selling drugs rose faster than its revenue....
Source : usnews-com
16:54 : Amgen net slips, offers strong sales outlook - SAN FRANCISCO (MarketWatch) -- Amgen Inc. reported late Thursday fourth-quarter net profit slipped to $934 million, or $1.08 a share, from $1.02 billion, or $1.08 a share, a year ago. Adjusted to exclude one-time items the company earned ...
Source : marketwatch-com
09:27 : Amgen to buy Micromet for over $1 billion - (Reuters) - Amgen Inc , the world's largest biotechnology company, said on Thursday it would pay over $1 billion to buy Micromet Inc , which has several cancer drugs in development.
Source : reuters-com
08:38 : Amgen to buy Micromet for $1.16 billion - NEW YORK (AP) -- Amgen Inc. is buying Micromet Inc., a developer of cancer therapies, for $1.16 billion in cash in a bid to boost its oncology pipeline....
Source : usnews-com
08:24 : More on Amgen (AMGN) / Micromet (MITI) deal: The acquisition provides ... - More on Amgen (AMGN) / Micromet (MITI) deal: The acquisition provides Amgen with blinatumomab, a leukemia treatment in Phase 2 trials. The offer of $11/share is a 33% premium to Micromet's close yesterday. (PR) ...
Source : seekingalpha-com

Amgen 1/9/2012

14:53 : Next Amgen CEO sees more markets, higher sales - SAN FRANCISCO (AP) -- Amgen Inc.'s next CEO says he expects revenue to grow this year as sales pick up for some recently launched products and the company expands operations overseas....
Source : usnews-com

Amgen 1/6/2012

10:29 : Lagging biotechs Amgen ([[AMGN]] -0.2%) and Celgene ([[CELG]] -2%) may ... - Lagging biotechs Amgen (AMGN -0.2%) and Celgene (CELG -2%) may dive into deal-making this year in seeking to return to the industry's high-growth roots, Bloomberg speculates. Investors in the space have rewarded strategic acquisitions ...
Source : seekingalpha-com

Amgen 12/19/2011

19:28 : Amgen, Watson partner on 'biosimilar' cancer drugs - TRENTON, New Jersey (AP) -- The world's biggest biotech firm and a leading generic drugmaker said Monday they are teaming up to produce "biosimilar" versions of several biologic medicines for cancer, an important partnership in a future niche that many ...
Source : usnews-com

Amgen 12/16/2011

16:31 : Amgen names new CEO, raises quarterly dividend - Amgen Inc (AMGN.O), the world's largest biotechnology company, said Chief Executive Officer Kevin Sharer will retire next May, and be replaced by Chief Operating Officer Bob Bradway.
Source : ibtimes-com
05:55 : Amgen (AMGN) CEO Kevin Sharer will retire in May and be replaced by compan - Amgen (AMGN) CEO Kevin Sharer will retire in May and be replaced by company President and COO Robert Bradway. RBC Capital analyst Michael Yee says the biotech's new CEO will need to "reinvigorate a focus of innovation for ...
Source : seekingalpha-com

Amgen 12/15/2011

16:46 : Amgen Chairman, CEO Kevin Sharer to retire - SAN FRANCISCO (MarketWatch) -- Amgen said late Thursday Chairman and Chief Executive Officer Kevin Sharer will retire as chief executive on May 23 and then relinquish his chairman title at the end of 2012. Chief Operating ...
Source : marketwatch-com
16:09 : Amgen (AMGN) rises slightly after boosting its quarterly dividend by $0.08 - Amgen (AMGN) rises slightly after boosting its quarterly dividend by $0.08/share, to $0.36/share. Following the hike, Amgen sports an annual yield of 2.5%. Post your comment!
Source : seekingalpha-com

Amgen 12/13/2011

19:12 : Amgen (AMGN) says data from Phase 3 tests for its immune thrombocytopenia - Amgen (AMGN) says data from Phase 3 tests for its immune thrombocytopenia drug Nplate showed postitive results, and was presented at the 53rd Annual Meeting and Exposition of the American Society of Hematology over the weekend in San Diego. ...
Source : seekingalpha-com

Amgen 12/8/2011

12:51 : Biotech firm Amgen (AMGN) expects to repurchase almost $5B worth of stock - Biotech firm Amgen (AMGN) expects to repurchase almost $5B worth of stock - or around 83.3M shares at $60 a pop - following a Dutch auction. The buyback represents about half of a $10B program. Shares +0.4%. (PR) Post your comment!
Source : seekingalpha-com
actualidad Amgen -
Logo Amgen

Amgen by date


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts